A look at Chief Opechancanough, possibly the first known case of MG
Columnist Mark Harrington, a retired history teacher, reflects on the life of Chief Opechancanough, who led the Powhatan Confederacy.| Myasthenia Gravis News
Columnist Mark Harrington, a retired history teacher, reflects on the life of Chief Opechancanough, who led the Powhatan Confederacy.| Myasthenia Gravis News
Circulating inflammatory molecules called cytokines may be associated with a risk for developing myasthenia gravis, a recent study suggests.| Myasthenia Gravis News
Columnist Allen Francis says that his twin with MG finds chewing and swallowing more difficult as they both get older.| Myasthenia Gravis News
Gefurulimab outperformed a placebo in easing gMG symptoms in a clinical trial involving over 250 patients positive for anti-AChR antibodies.| Myasthenia Gravis News
The anti-inflammatory therapy telitacicept for myasthenia gravis was granted orphan drug status in the EU by the European Medicines Agency.| Myasthenia Gravis News
Povetacicept reduced disease activity in a mouse model of MG by reducing the levels of disease-causing antibodies in the bloodstream.| Myasthenia Gravis News
Vor Bio signed an exclusive license agreement to develop and market Remegen’s telitacicept for MG outside China, Hong Kong, Macau, and Taiwan.| Myasthenia Gravis News
Thymectomy led to a long-term reduction in the levels of immune T-cells and to temporary changes in cytokine levels in MG patients.| Myasthenia Gravis News
Two women with severe, treatment-resistant MG responded well to the cancer medication blinatumomab, according to a case report.| Myasthenia Gravis News
Columnist Shawna Barnes describes the different types of air hunger she experiences with MG, as well as their probable causes.| Myasthenia Gravis News
Exercise and physiotherapy can improve muscle strength, alleviate fatigue, and boost quality of life for people with myasthenia gravis.| Myasthenia Gravis News
Immunosuppressants, a class of medicines that broadly work to reduce immune system activity, are widely used to treat myasthenia gravis (MG).| Myasthenia Gravis News
Researchers say the case suggests Vyvgart can be an alternative drug for achieving minimal manifestation status during a myasthenic crisis.| Myasthenia Gravis News
More than half of MG patients in a study had fatigue and its severity correlated with disease worsening, crises, and delays in diagnosis.| Myasthenia Gravis News
Rituximab isn't officially approved for MG, but is used off-label when standard treatments fail, such as patients with anti-MuSK antibodies.| Myasthenia Gravis News
Columnist Shawna Barnes shares the hard-earned wisdom that would've helped her navigate life with myasthenia gravis after her diagnosis.| Myasthenia Gravis News
More than a quarter of gMG patients wait more than one year to receive an accurate diagnosis, according to study of five European countries.| Myasthenia Gravis News
An open-label, multicenter Phase 2 clinical trial will test KYV-101 in people with refractory MG and positive for self-reactive antibodies.| Myasthenia Gravis News
Vyvgart is an approved infusion treatment for adults with generalized myasthenia gravis who are AChR-antibody positive.| Myasthenia Gravis News
Rystiggo is a myasthenia gravis treatment for adults with generalized MG. It's administered as an injection.| Myasthenia Gravis News
Batoclimab is an experimental antibody therapy being developed for generalized myasthenia gravis, along with other autoimmune disorders.| Myasthenia Gravis News
Columnist Shawna Barnes, who has seronegative myasthenia gravis, is happy with her treatments and sees no reason now to change them.| Myasthenia Gravis News
Getting a correct myasthenia gravis diagnosis may require a series of blood, nerve, muscle, and imaging tests.| Myasthenia Gravis News
Living with myasthenia gravis can be challenging, but the right strategies can help you manage your symptoms and ease their effects.| Myasthenia Gravis News
Fatigue linked to myasthenia gravis can affect a person’s quality of life, but there are coping strategies that can be used to minimize it.| Myasthenia Gravis News
When symptoms of myasthenia gravis and a crisis left him so exhausted he wanted to give up, columnist Mark Harrington relied on his tenacity.| Myasthenia Gravis News
Soliris (eculizumab) is an infusion therapy approved for treating adults with generalized myasthenia gravis.| Myasthenia Gravis News
Myasthenia gravis occurs when self-reactive antibodies mistakenly attack the body's immune system, causing muscle weakness and fatigue.| Myasthenia Gravis News
Columnist Shawna Barnes shares three things she wishes she'd done differently in pursuit of a myasthenia gravis diagnosis.| Myasthenia Gravis News
Thymectomy removes the thymus gland, aiming to cause remission from myasthenia gravis symptoms and a decrease in the need for medications.| Myasthenia Gravis News
Plasmapheresis is a treatment for myasthenia gravis, commonly used during a myasthenic crisis and in preparation for thymectomy.| Myasthenia Gravis News
Mestinon (pyridostigmine bromide) is an oral therapy approved for the treatment of myasthenia gravis (MG).| Myasthenia Gravis News
Remegen enrolled the first U.S. patient in a Phase 3 trial testing the safety and efficacy of telitacicept for generalized myasthenia gravis.| Myasthenia Gravis News
The anti-malaria drug dihydroartemisinin, known as DHA, showed promise for treating myasthenia gravis in a rat model of MG, per a new study.| Myasthenia Gravis News
Myasthenia gravis and summer heat are not friends, but these tactics have helped columnist Shawna Barnes reduce her heat intolerance.| Myasthenia Gravis News
People with gMG with difficulty getting diagnosed or hard-to-manage disease symptoms accrue higher healthcare-related costs, per a study.| Myasthenia Gravis News
Scientists have identified a set of inflammatory molecules that could be useful as biomarkers to aid in MG diagnosis and classification.| Myasthenia Gravis News
Myasthenia gravis is a neuromuscular disease characterized by weakness and fatigue that can affect muscles involved in voluntary movements.| Myasthenia Gravis News
